Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Immediate effects of diaphragmatic myofascial release on the physical and functional outcomes in sedentary women: A randomized placebo-controlled trial.

Marizeiro DF, Florêncio ACL, Nunes ACL, Campos NG, Lima POP.

J Bodyw Mov Ther. 2018 Oct;22(4):924-929. doi: 10.1016/j.jbmt.2017.10.008. Epub 2017 Oct 25.

PMID:
30368336
2.

Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis.

Campos NG, Tsu V, Jeronimo J, Regan C, Resch S, Clark A, Sy S, Kim JJ.

Int J Cancer. 2019 Feb 15;144(4):687-696. doi: 10.1002/ijc.31823. Epub 2018 Oct 16.

PMID:
30132850
3.

Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study.

Campos NG, Lince-Deroche N, Chibwesha CJ, Firnhaber C, Smith JS, Michelow P, Meyer-Rath G, Jamieson L, Jordaan S, Sharma M, Regan C, Sy S, Liu G, Tsu V, Jeronimo J, Kim JJ.

J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):195-205. doi: 10.1097/QAI.0000000000001778.

4.

Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.

Mezei AK, Pedersen HN, Sy S, Regan C, Mitchell-Foster SM, Byamugisha J, Sekikubo M, Armstrong H, Rawat A, Singer J, Ogilvie GS, Kim JJ, Campos NG.

BMJ Open. 2018 Jun 12;8(6):e020484. doi: 10.1136/bmjopen-2017-020484.

5.

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country.

Burger EA, Campos NG, Sy S, Regan C, Kim JJ.

Vaccine. 2018 Aug 6;36(32 Pt A):4823-4829. doi: 10.1016/j.vaccine.2018.04.061. Epub 2018 May 26.

6.

Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S.

Castle PE, Wheeler CM, Campos NG, Sy S, Burger EA, Kim JJ; New Mexico HPV Pap Registry Steering Committee.

Prev Med. 2018 Jun;111:177-179. doi: 10.1016/j.ypmed.2018.03.011. Epub 2018 Mar 14.

PMID:
29548787
7.

Effects of respiratory muscle training on endothelium and oxidative stress biomarkers in hemodialysis patients: A randomized clinical trial.

Campos NG, Marizeiro DF, Florêncio ACL, Silva ÍC, Meneses GC, Bezerra GF, Martins AMC, Libório AB.

Respir Med. 2018 Jan;134:103-109. doi: 10.1016/j.rmed.2017.12.005. Epub 2017 Dec 7.

PMID:
29413495
8.

Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study.

Campos NG, Tsu V, Jeronimo J, Mvundura M, Kim JJ.

BMC Cancer. 2017 Nov 25;17(1):791. doi: 10.1186/s12885-017-3786-3.

9.

Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.

Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, Tosteson ANA.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):158-164. doi: 10.1158/1055-9965.EPI-17-0378. Epub 2017 Nov 17.

PMID:
29150480
10.

Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.

Campos NG, Tsu V, Jeronimo J, Njama-Meya D, Mvundura M, Kim JJ.

Health Policy Plan. 2017 Dec 1;32(10):1491. doi: 10.1093/heapol/czx076. No abstract available.

11.

The Cost-Effectiveness of Visual Triage of Human Papillomavirus-Positive Women in Three Low- and Middle-Income Countries.

Campos NG, Jeronimo J, Tsu V, Castle PE, Mvundura M, Kim JJ.

Cancer Epidemiol Biomarkers Prev. 2017 Oct;26(10):1500-1510. doi: 10.1158/1055-9965.EPI-16-0787. Epub 2017 Jul 14.

12.

Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings.

Campos NG, Tsu V, Jeronimo J, Mvundura M, Kim JJ.

Cancer Med. 2017 Aug;6(8):2008-2014. doi: 10.1002/cam4.1123. Epub 2017 Jul 14.

13.

The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.

Campos NG, Sharma M, Clark A, Lee K, Geng F, Regan C, Kim J, Resch S.

Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:47-56. doi: 10.1002/ijgo.12184.

14.

Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.

Campos NG, Mvundura M, Jeronimo J, Holme F, Vodicka E, Kim JJ.

BMJ Open. 2017 Jun 15;7(6):e015048. doi: 10.1136/bmjopen-2016-015048.

15.

Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.

Campos NG, Tsu V, Jeronimo J, Njama-Meya D, Mvundura M, Kim JJ.

Health Policy Plan. 2017 Sep 1;32(7):956-968. doi: 10.1093/heapol/czw182.

16.

Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review.

Mezei AK, Armstrong HL, Pedersen HN, Campos NG, Mitchell SM, Sekikubo M, Byamugisha JK, Kim JJ, Bryan S, Ogilvie GS.

Int J Cancer. 2017 Aug 1;141(3):437-446. doi: 10.1002/ijc.30695. Epub 2017 Apr 3. Review.

17.

Gait stability, variability and complexity on inclined surfaces.

Vieira MF, Rodrigues FB, de Sá E Souza GS, Magnani RM, Lehnen GC, Campos NG, Andrade AO.

J Biomech. 2017 Mar 21;54:73-79. doi: 10.1016/j.jbiomech.2017.01.045. Epub 2017 Feb 6.

PMID:
28233553
18.

To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings.

Campos NG, Tsu V, Jeronimo J, Mvundura M, Lee K, Kim JJ.

Int J Cancer. 2017 Mar 15;140(6):1293-1305. doi: 10.1002/ijc.30551.

19.

Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.

Kim JJ, Burger EA, Sy S, Campos NG.

J Natl Cancer Inst. 2016 Oct 18;109(2). pii: djw216. Print 2017 Feb.

20.

Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries.

Campos NG, Sharma M, Clark A, Kim JJ, Resch SC.

PLoS One. 2016 Oct 6;11(10):e0164000. doi: 10.1371/journal.pone.0164000. eCollection 2016.

21.

Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.

Kim JJ, Campos NG, Sy S, Burger EA, Cuzick J, Castle PE, Hunt WC, Waxman A, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Ann Intern Med. 2015 Oct 20;163(8):589-97. doi: 10.7326/M15-0420. Epub 2015 Sep 29.

22.

Cancer Screening Utilization Among Immigrant Women in Miami, Florida.

Seay JS, Carrasquillo O, Campos NG, McCann S, Amofah A, Pierre L, Kobetz E.

Prog Community Health Partnersh. 2015;9 Suppl:11-20. doi: 10.1353/cpr.2015.0029.

PMID:
26213400
23.

Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.

Campos NG, Castle PE, Wright TC Jr, Kim JJ.

Int J Cancer. 2015 Nov 1;137(9):2208-19. doi: 10.1002/ijc.29594. Epub 2015 May 21.

24.

The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador.

Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Cremer ML, Kim JJ.

Int J Cancer. 2015 Aug 15;137(4):893-902. doi: 10.1002/ijc.29438. Epub 2015 Feb 3.

25.

An updated natural history model of cervical cancer: derivation of model parameters.

Campos NG, Burger EA, Sy S, Sharma M, Schiffman M, Rodriguez AC, Hildesheim A, Herrero R, Kim JJ.

Am J Epidemiol. 2014 Sep 1;180(5):545-55. doi: 10.1093/aje/kwu159. Epub 2014 Jul 31.

26.

Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.

Kim JJ, Campos NG, O'Shea M, Diaz M, Mutyaba I.

Vaccine. 2013 Dec 29;31 Suppl 5:F60-72. doi: 10.1016/j.vaccine.2012.07.093.

PMID:
24331749
27.

Potential benefits of second-generation human papillomavirus vaccines.

Kiatpongsan S, Campos NG, Kim JJ.

PLoS One. 2012;7(11):e48426. doi: 10.1371/journal.pone.0048426. Epub 2012 Nov 7.

28.

Burden of Human Papillomavirus among Haitian Immigrants in Miami, Florida: Community-Based Participatory Research in Action.

Kobetz E, Kish JK, Campos NG, Koru-Sengul T, Bishop I, Lipshultz H, Barton B, Barbee L.

J Oncol. 2012;2012:728397. doi: 10.1155/2012/728397. Epub 2012 Mar 15.

29.

Policy implications of adjusting randomized trial data for economic evaluations: a demonstration from the ASCUS-LSIL Triage Study.

Campos NG, Castle PE, Schiffman M, Kim JJ.

Med Decis Making. 2012 May-Jun;32(3):400-27. doi: 10.1177/0272989X11428516. Epub 2011 Dec 6.

30.

Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa.

Campos NG, Kim JJ, Castle PE, Ortendahl JD, O'Shea M, Diaz M, Goldie SJ.

Int J Cancer. 2012 Jun 1;130(11):2672-84. doi: 10.1002/ijc.26269. Epub 2011 Aug 24.

31.

Persistence of concurrent infections with multiple human papillomavirus types: a population-based cohort study.

Campos NG, Rodriguez AC, Castle PE, Herrero R, Hildesheim A, Katki H, Kim JJ, Wacholder S, Morales J, Burk RD, Schiffman M.

J Infect Dis. 2011 Mar 15;203(6):823-7. doi: 10.1093/infdis/jiq131. Epub 2011 Jan 21.

32.

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.

Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY.

Vaccine. 2008 Jul 29;26(32):4080-93. doi: 10.1016/j.vaccine.2008.04.053. Epub 2008 May 15.

PMID:
18550229
33.

Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV.

Campos NG, Salomon JA, Servoss JC, Nunes DP, Samet JH, Freedberg KA, Goldie SJ.

Am J Med. 2007 Mar;120(3):272-9.

34.

New malaise: bioethics and human rights in the global era.

Farmer P, Campos NG.

J Law Med Ethics. 2004 Summer;32(2):243-51, 190-1.

PMID:
15301189
35.

Rethinking medical ethics: a view from below.

Farmer P, Campos NG.

Dev World Bioeth. 2004 May;4(1):17-41.

PMID:
15086372

Supplemental Content

Loading ...
Support Center